...
首页> 外文期刊>Molecules >A Herbal Formula HT048, Citrus unshiu and Crataegus pinnatifida, Prevents Obesity by Inhibiting Adipogenesis and Lipogenesis in 3T3-L1 Preadipocytes and HFD-Induced Obese Rats
【24h】

A Herbal Formula HT048, Citrus unshiu and Crataegus pinnatifida, Prevents Obesity by Inhibiting Adipogenesis and Lipogenesis in 3T3-L1 Preadipocytes and HFD-Induced Obese Rats

机译:草药配方HT048,柑桔和山楂(Cretaegus pinnatifida)通过抑制3T3-L1前脂肪细胞和HFD诱导的肥胖大鼠的脂肪形成和脂肪生成来预防肥胖。

获取原文
获取原文并翻译 | 示例

摘要

HT048 is a combination composed of Crataegus pinnatifida leaf and Citrus unshiu peel extracts. This study aimed to investigate potential anti-obesity effect of the combination. The 3T3-L1 adipocytes were treated with different doses of HT048 and triglyceride accumulation, glycerol release and adipogenesis-related genes were analyzed. For in vivo study, male Sprague Dawley rats were divided according to experimental diets: the chow diet group, the high-fat diet (HFD) group, the HFD supplemented with orlistat group, the HFD supplemented with HT048 group (0.2% or 0.4%) for 12 weeks. We measured the body weight, serum lipid levels and the expression of genes involved lipid metabolism. HT048 treatment dose-dependently suppressed adipocyte differentiation and stimulated glycerol release. The expressions of PPAR and C/EBP mRNA were decreased by HT048 treatment in adipocytes. HT048 supplementation significantly reduced the body and fat weights in vivo. Serum lipid levels were significantly lower in the HT048 supplemented groups than those of the HFD group. Expression of the hepatic lipogenesis-related genes were decreased and expression of the -oxidation-related genes were increased in rats fed HT048 compared to that of animals fed HFD. These results suggest that HT048 has a potential benefit in preventing obesity through the inhibition of lipogenesis and adipogenesis.
机译:HT048是由Crataegus pinnatifida叶和柑桔皮提取物组成的组合。这项研究旨在研究该组合的潜在抗肥胖作用。用不同剂量的HT048处理3T3-L1脂肪细胞,并分析甘油三酸酯的积累,甘油的释放以及与脂肪形成相关的基因。为了进行体内研究,根据实验饮食对雄性Sprague Dawley大鼠进行了划分:食物饮食组,高脂饮食(HFD)组,HFD补充奥利司他组,HFD补充HT048组(0.2%或0.4% ),持续12周。我们测量了体重,血清脂质水平和涉及脂质代谢的基因表达。 HT048处理剂量依赖性地抑制了脂肪细胞的分化并刺激了甘油的释放。 HT048处理可降低脂肪细胞中PPAR和C / EBP mRNA的表达。 HT048补充剂可显着降低体内的脂肪和体重。补充HT048的组的血脂水平显着低于HFD组。与饲喂HFD的动物相比,饲喂HT048的大鼠的肝脏脂肪生成相关基因的表达减少,而与氧化相关的基因表达增加。这些结果表明,HT048通过抑制脂肪生成和脂肪生成,在预防肥胖方面具有潜在的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号